TrialJournal of gastroenterology2013

The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial.

Takeshi Tsujino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.